App-Quantinova.ai

Perioperative Blood Product Utilization And Blood Donor Exposure In Patients With Single Ventricle Physiology

Bill McElroy - American Society of Anesthesiologists (ASA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Risk Factors For Perioperative Thrombosis In Neonatal Congenital Cardiac Patients

Laura Downey - American Society of Anesthesiologists (ASA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Assessing Coagulation Profiles Prior Bariatric Surgery With Thrombelastography

Davide Cattano - American Society of Anesthesiologists (ASA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Monit

SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes

Jacob G Ludington - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Phosphatidylserine

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Dennis Lund Hansen - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

P-Selectin Deficiency Reduces Acute Vascular Complications but Not Chronic Organ Damage in Sickle Cell Mice

Erica Sparkenbaugh - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

SelG1

Inhibition of Factor XII Attenuates Prothrombotic Complications in Sickle Cell Mice

Erica Sparkenbaugh - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Activation of Pyruvate Kinase-R with Etavopivat (FT-4202) Is Well Tolerated, Improves Anemia, and Decreases Intravascular Hemolysis in Patients with Sickle Cell Disease Treated for up to 12 Weeks

R. Clark Clark Brown - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

GRK2 Regulates ADP Signaling in Platelets Via P2Y 1 and P2Y 12

Xuefei Zhao - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Prostaglandin

Fc-Modified Kko: A Novel Therapeutic for Heparin-Induced Thrombocytopenia (HIT), Reversing Both the Thrombocytopenia and Thrombosis

Amrita Sarkar - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ

Caroline Vayne - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Human Prothrombin Variants with Modifications in the Active Site S4 Subpocket Demonstrate Resistance to Dabigatran

Viola J.F. Strijbis - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Chymex

An Intergenic Noncoding Chromosome 18 Variant Suppresses Lethal Thrombosis in Mice By Normalizing Blood Coagulation and Reducing Platelet Reactivity

Marisa A Brake - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

A Cross-Sectional Study of the American Thrombosis and Hemostasis Network Dataset for Outcomes of Dental Extractions in People with Hemophilia

Heather Messenger - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hemostatic Solution

Protective Effects of Kininogen-1 Gene Deficiency in Mouse Models of Venous Thrombosis

Aatira Vijay - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Dex-HEMA

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Meaghan Colling - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Vaccine-Induced Thrombocytopenia and Thrombosis (VITT) Antibodies Recognize Neutrophil-Activating Peptide 2 (NAP2) As Well As Platelet Factor 4 (PF4): Mechanistic and Clinical Implications

Lubica Rauova - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Predictive Value for Increased Factor XIa and Plasma Kallikrein Activity in Acute Venous Thromboembolism

Magdolna Nagy - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Alpha 1-Antitrypsin

Identification of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence Estimated By the Vienna Prediction Model: A Prospective Cohort Management Study

Sabine Eichinger - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Jameel Abdulrehman - American Society of Hematology (ASH) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Filters

7277 Abstracts